Home › Funds › D. E. Shaw & Co › EBS
D. E. Shaw & Co position in EBS
EMERGENT BIOSOLUTIONS INC · Health Care
Latest position (Q2 2026)900.11K sh
Reported value held$7.54M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 62.45K | $3.13M | New |
| Q4 2021 | 945.34K | $41.09M | Add |
| Q1 2022 | 1.16M | $47.78M | Add |
| Q2 2022 | 1.07M | $33.09M | Reduce |
| Q3 2022 | 992.21K | $20.83M | Reduce |
| Q4 2022 | 1.63M | $19.27M | Add |
| Q1 2023 | 1.36M | $14.13M | Reduce |
| Q2 2023 | 977.92K | $7.19M | Reduce |
| Q3 2023 | 936.52K | $3.18M | Reduce |
| Q4 2023 | 1.19M | $2.85M | Add |
| Q1 2024 | 416.66K | $1.05M | Reduce |
| Q2 2024 | 827.80K | $5.65M | Add |
| Q3 2024 | 771.14K | $6.44M | Reduce |
| Q4 2024 | 383.04K | $3.66M | Reduce |
| Q1 2025 | 272.27K | $1.32M | Reduce |
| Q2 2025 | 411.37K | $2.62M | Add |
| Q3 2025 | 321.17K | $2.83M | Reduce |
| Q4 2025 | 723.22K | $8.94M | Add |
| Q1 2026 | 1.00M | $8.33M | Add |
| Q2 2026 | 900.11K | $7.54M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding EBS
- Vanguard Group 3.55M sh · $43.93M · Q4 2025
- BlackRock Inc 4.72M sh · $39.53M · Q2 2026
- Geode Capital Management 1.34M sh · $11.21M · Q2 2026
- Charles Schwab Investment Management 1.20M sh · $10.06M · Q2 2026
- Millennium Management 1.07M sh · $8.98M · Q2 2026
- AQR Capital Management 1.04M sh · $8.72M · Q2 2026
- Goldman Sachs Group 1.04M sh · $8.68M · Q2 2026
- Prudential Financial 805.89K sh · $6.75M · Q2 2026
- Renaissance Technologies 683.25K sh · $5.73M · Q2 2026
- Northern Trust Corp 621.47K sh · $5.21M · Q2 2026
- Two Sigma Investments 488.28K sh · $4.09M · Q2 2026